Vimarsana
Biggest News Aggregation in the World

Page 2 - Celcuity Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Celcuity Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Celcuity Inc Today - Breaking & Trending Today

Celcuity Inc. (NASDAQ:CELC) Q1 2024 Earnings Call Transcript - Vimarsana News

Celcuity Inc. (NASDAQ:CELC) Q1 2024 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. And welcome the Celcuity First Quarter 2024 Financial Results Conference call. At this time, all lines are in a listen-only mode.

Celcuity (NASDAQ:CELC) Given Buy Rating at Craig Hallum - Vimarsana News

Celcuity (NASDAQ:CELC) Given Buy Rating at Craig Hallum

Celcuity (NASDAQ:CELC – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Craig Hallum in a report issued on Thursday, Benzinga reports. They presently have a $27.00 price objective on the stock, up from their previous price objective of $25.00. Craig Hallum’s price target points to a potential upside of 51.09% […]

Celcuity (NASDAQ:CELC) Shares Gap Up to $17.23 - Vimarsana News

Celcuity (NASDAQ:CELC) Shares Gap Up to $17.23

Celcuity Inc. (NASDAQ:CELC – Get Free Report) shares gapped up prior to trading on Thursday . The stock had previously closed at $17.23, but opened at $19.47. Celcuity shares last traded at $18.20, with a volume of 46,888 shares traded. Analyst Ratings Changes CELC has been the subject of a number of recent research reports. […]

Baystreet.ca - Biotech's Developments in Race Against Rising Cancer Rates Revealed - Vimarsana News

Baystreet.ca - Biotech's Developments in Race Against Rising Cancer Rates Revealed

USA News Group – According to a “highly troubling” new study, the rising number of cancer cases in young people is being attributed to “accelerated aging.” Further alarm is being spread by the United Nations, whose health ...

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 - Vimarsana News

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

/PRNewswire/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging."...